Guardant Health Inc annual net income for fiscal TTM was -$453 million, a decrease of 8.9% from -$416 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | ($453M) | ($416M) | ($436M) | ($479M) | ($655M) | ($406M) | ($254M) | ($76M) | ($85M) | ($83M) | ($46M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | ($120M) | ($112M) | ($128M) | ($93M) | ($100M) | ($95M) | ($111M) | ($108M) | ($103M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More GH metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All GH financial statements → Interactive GH charts →
About TickerBase · Data methodology & sources · Privacy · Terms